Mangoceuticals, Inc. (MGRX)
NASDAQ: MGRX · Real-Time Price · USD
2.549
+0.079 (3.20%)
Nov 21, 2024, 1:44 PM EST - Market open
Mangoceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 0.76 | 0.73 | 0.01 | - |
| Revenue Growth (YoY) | 52.20% | 8083.16% | - | - |
| Cost of Revenue | 0.31 | 0.3 | 0 | - |
| Gross Profit | 0.44 | 0.43 | 0 | - |
| Selling, General & Admin | 6.23 | 6.39 | 2 | 0.07 |
| Operating Expenses | 8.69 | 8.55 | 2 | 0.07 |
| Operating Income | -8.24 | -8.12 | -1.99 | -0.07 |
| Interest Expense | -0.47 | - | -0.01 | -0 |
| Other Non Operating Income (Expenses) | -0.61 | -1.09 | - | - |
| Pretax Income | -9.33 | -9.21 | -2 | -0.07 |
| Net Income | -9.33 | -9.21 | -2 | -0.07 |
| Net Income to Common | -9.33 | -9.21 | -2 | -0.07 |
| Shares Outstanding (Basic) | 2 | 1 | 1 | 1 |
| Shares Outstanding (Diluted) | 2 | 1 | 1 | 1 |
| Shares Change (YoY) | 69.51% | 49.22% | 34.98% | - |
| EPS (Basic) | -5.65 | -8.58 | -2.78 | - |
| EPS (Diluted) | -5.66 | -8.58 | -2.78 | - |
| Free Cash Flow | -5.43 | -7 | -1.39 | -0.07 |
| Free Cash Flow Per Share | -3.29 | -6.52 | -1.93 | -0.13 |
| Gross Margin | 58.60% | 58.99% | 54.26% | - |
| Operating Margin | -1091.84% | -1109.84% | -22279.70% | - |
| Profit Margin | -1235.21% | -1259.40% | -22352.11% | - |
| Free Cash Flow Margin | -719.46% | -957.07% | -15545.59% | - |
| EBITDA | -8.23 | -8.09 | -1.99 | - |
| D&A For EBITDA | 0.02 | 0.02 | 0 | - |
| EBIT | -8.24 | -8.12 | -1.99 | -0.07 |
Source: S&P Capital IQ. Standard template.
Financial Sources.